List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 415 studies with search of: "Ritonavir" [TREATMENT] AND HIV [CONDITION]
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Completed Efficacy and Safety of Single Versus Double Ritonavir-Boosted Protease Inhibitor (PI)-Based Antiretroviral Therapy (ART) Regimens
Conditions: HIV Infection;   HIV Infections
Interventions: Drug: ritonavir-boosted PI-based second line treatments;   Drug: two PIs boosted by low dose ritonavir or one PI plus full dose ritonavir
2 Recruiting Lopinavir/Ritonavir (Kaletra)PK
Conditions: HIV/AIDS Treatment;   HIV Infections
Intervention: Drug: lopinavir/ritonavir (Kaletra®) tablets
3 Active, not recruiting Comparison of Two Dosing Regimens of GW433908/Ritonavir Versus Lopinavir/Ritonavir for 48 Weeks in HIV Patients Who Have Taken Protease Inhibitors and Experienced Virological Failure
Condition: HIV Infections
Interventions: Drug: Lopinavir/Ritonavir;   Drug: Ritonavir;   Drug: GW433908
4 Recruiting Evaluation of Three Strategies of Second-line Antiretroviral Treatment in Africa (Dakar - Bobo-Dioulasso - Yaoundé)
Conditions: HIV;   HIV Infections
Interventions: Drug: emtricitabine/tenofovir + lopinavir/ritonavir (WHO recommended second line);   Drug: abacavir + didanosine + lopinavir/ritonavir (WHO recommended second line);   Drug: emtricitabine/tenofovir + darunavir + ritonavir (Second line strategy under evaluation)
5 Completed Dual Versus Triple Protease Inhibitor Combinations, Including Ritonavir, in HIV Infected People
Condition: HIV Infections
Interventions: Drug: Fosamprenavir;   Drug: Lopinavir/Ritonavir;   Drug: Ritonavir;   Drug: Tenofovir disoproxil fumarate
6 Recruiting A Study to Assess the Pharmacokinetics (Blood Levels) of TMC114 (Darunavir) Taken With TMC114r (Ritonavir), and TMC125 (Etravirine) in HIV-1 Infected Pregnant Women
Conditions: HIV;   HIV Infections;   Pregnancy
Interventions: Drug: TMC114r (ritonavir);   Drug: TMC114 (darunavir);   Drug: TMC125 (etravirine)
7 Recruiting Study to Determine the Pharmacokinetic Behavior of Antiretroviral Drugs in Patients Infected by HIV
Condition: HIV Infections
Interventions: Drug: Nevirapine;   Drug: Efavirenz;   Drug: Indinavir/ritonavir;   Drug: Nelfinavir;   Drug: Saquinavir/ritonavir;   Drug: Lopinavir/ritonavir;   Drug: Atazanavir;   Drug: Atazanavir/ritonavir;   Drug: Fos-amprenavir/ritonavir;   Drug: Tipranavir/ ritonavir;   Drug: Darunavir/ritonavir
8 Active, not recruiting Study in Healthy Males to Measure Darunavir and Etravirine in Blood, Seminal Fluid, and Rectal Tissue
Conditions: HIV/AIDS;   HIV Infections
Interventions: Drug: darunavir;   Drug: Ritonavir;   Drug: Etravirine
9 Active, not recruiting Darunavir/Ritonavir and Rosuvastatin Pharmacokinetic Study
Condition: HIV Infections
Interventions: Drug: darunavir, ritonavir, rosuvastatin;   Drug: rosuvastatin, darunavir, ritonavir
10 Not yet recruiting Pilot Study to Evaluate HIV Viremia and Persistence in Acutely HIV-Infected Antiretroviral Naïve Patients Treated With Darunavir/Ritonavir and Etravirine
Conditions: Acute HIV Infection;   HIV Infections
Intervention: Drug: Darunavir/Ritonavir and Etravirine
11 Not yet recruiting Randomised and Prospective Clinical Study to Evaluate the Efficacy and Safety of Lopinavir/Ritonavir Monotherapy Versus Darunavir/Ritonavir Monotherapies as Simplification Switching Strategies of PI/NNRTI-Triple Therapy Based-Regimens
Condition: HIV Infections
Interventions: Drug: Darunavir/ritonavir;   Drug: Lopinavir/ritonavir
12 Completed Drug Interaction Study With Famotidine, Atazanavir, and Atazanavir/Ritonavir/Tenofovir
Condition: HIV Infections
Interventions: Drug: Atazanavir+Ritonavir+Tenofovir;   Drug: Atazanavir+Ritonavir+Tenofovir+Famotidine
13 Completed Pharmacokinetic Study of Two Generic co-Formulations of Lopinavir/Ritonavir for HIV Infected Children (SURF)
Condition: HIV Infections
Intervention: Drug: Lopinavir/ritonavir
14 Completed Dose Reduction of Lopinavir in Children
Condition: HIV Infections
Interventions: Drug: Lopinavir/ritonavir standard dose According to WHO simplified dosing table;   Drug: Lopinavir/ritonavir low dose ( 70% of WHO recommended dosing table)
15 Completed Amprenavir/Ritonavir, Saquinavir/Ritonavir or Efavirenz in HIV-Infected Subjects Following Failure With Kaletra (ABT-378/Ritonavir) as Their First Protease Inhibitor Based HAART
Condition: HIV Infections
Interventions: Drug: Amprenavir/ritonavir;   Drug: Saquinavir/ritonavir;   Drug: Efavirenz
16 Completed Amprenavir/Ritonavir or Saquinavir/Ritonavir in HIV-Infected Subjects Following Failure With Kaletra as Their Second Protease Inhibitor
Condition: HIV Infections
Interventions: Drug: Amprenavir/ritonavir;   Drug: Saquinavir/ritonavir
17 Active, not recruiting "The Once A Day Protease Inhibitor Regimens"
Conditions: HIV Infections;   Antiretroviral Therapy
Interventions: Drug: ritonavir-boosted atazanavir;   Drug: ritonavir-boosted fosamprenavir
18 Terminated Safety and Efficacy of Kaletra in ARV Therapy Experienced Patients
Conditions: HIV Infections;   Kaletra
Interventions: Drug: lopinavir/ritonavir;   Drug: lopinavir /ritonavir
19 Completed A Study of Ritonavir (ABT-538) When Used With Nelfinavir in HIV-Infected Patients
Condition: HIV Infections
Interventions: Drug: Ritonavir;   Drug: Nelfinavir mesylate
20 Completed ABT-378/Ritonavir in Combination With Reverse Transcriptase Inhibitors in Antiretroviral Naïve HIV-Infected Subjects
Condition: HIV Infections
Interventions: Drug: Lopinavir/Ritonavir;   Drug: Lamivudine;   Drug: Stavudine

Previous Page Studies Shown (1-20) Next Page (21-40)
Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
RSS Feeds for studies found by your search that were:
  First received in the last 14 days,  
  Last updated (includes received) in the last 30 days
  Download Options




Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services